The Michael J. Fox Foundation’s Strategies for Accelerating Translation of LRRK2 into Therapies for Parkinson Disease

by Shalini Padmanabhan, Brian K. Fiske, Marco A.S. Baptista
Published 2020-08-01

The Michael J. Fox Foundation for Parkinson’s Research Strategy to Advance Therapeutic Development of PINK1 and Parkin

by Shalini Padmanabhan, Nicole K. Polinski, Liliana B. Menalled, Marco A.S. Baptista, Brian K. Fiske
Published 2019-07-01

A strategy for the generation, characterization and distribution of animal models by The Michael J. Fox Foundation for Parkinson’s Research

by Marco A. S. Baptista, Kuldip D. Dave, Niketa P. Sheth, Shehan N. De Silva, Kirsten M. Carlson, Yasmin N. Aziz, Brian K. Fiske, Todd B. Sherer, Mark A. Frasier
Published 2013-11-01

Loss of leucine-rich repeat kinase 2 (LRRK2) in rats leads to progressive abnormal phenotypes in peripheral organs.

by Marco A S Baptista, Kuldip D Dave, Mark A Frasier, Todd B Sherer, Melanie Greeley, Melissa J Beck, Julie S Varsho, George A Parker, Cindy Moore, Madeline J Churchill, Charles K Meshul, Brian K Fiske
Published 2013-01-01

Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease

by Kuldip D. Dave, Shehan De Silva, Niketa P. Sheth, Sylvie Ramboz, Melissa J. Beck, Changyu Quang, Robert C. Switzer, III, Syed O. Ahmad, Susan M. Sunkin, Dan Walker, Xiaoxia Cui, Daniel A. Fisher, Aaron M. McCoy, Kevin Gamber, Xiaodong Ding, Matthew S. Goldberg, Stanley A. Benkovic, Meredith Haupt, Marco A.S. Baptista, Brian K. Fiske, Todd B. Sherer, Mark A. Frasier
Published 2014-10-01